A rare genetic disorder called CMAMMA can hide behind irritable bowel syndrome symptoms for years, as shown in a 2026 case report where one patient went undiagnosed for 15 years before genetic testing revealed an ACSF3 gene mutation. According to Gram Research analysis, this patient’s digestive symptoms worsened on high-carbohydrate diets, the opposite of standard IBS treatment, suggesting CMAMMA requires personalized dietary approaches. While extremely rare, CMAMMA should be considered when digestive and fatigue symptoms remain unexplained despite extensive testing.
A groundbreaking case study reveals how a rare genetic disorder called CMAMMA can hide behind common digestive problems like irritable bowel syndrome for decades. According to Gram Research analysis, one patient suffered unexplained fatigue and gut issues for 15 years before genetic testing uncovered the true culprit: a mutation in the ACSF3 gene that disrupts how the body produces energy. The discovery suggests that some people diagnosed with IBS may actually have this rare metabolic disorder, and that high-carbohydrate diets, often recommended for similar conditions, can actually make things worse for CMAMMA patients.
Key Statistics
A 2026 case report published in JIMD Reports documented one adult patient with unexplained fatigue and irritable bowel symptoms who remained undiagnosed for 15 years before genetic testing identified a pathogenic ACSF3 variant (c.1672C>T) causing combined malonic and methylmalonic aciduria.
In this CMAMMA case, a high-carbohydrate, low-protein diet, standard treatment for related metabolic disorders, caused pronounced worsening of gastrointestinal symptoms, which improved after discontinuation, suggesting CMAMMA patients may require different dietary management than currently recommended.
Cellular studies in the CMAMMA patient showed markedly reduced lipoylation of pyruvate dehydrogenase complex and α-ketoglutarate dehydrogenase, indicating impaired mitochondrial energy metabolism as the underlying cause of chronic fatigue and digestive dysfunction.
The Quick Take
- What they studied: Whether a rare genetic disorder affecting energy production could be mistaken for irritable bowel syndrome and how diet affects patients with this condition
- Who participated: One adult patient with a 15-year history of unexplained fatigue and digestive problems who was finally diagnosed through genetic testing
- Key finding: A single ACSF3 gene mutation was identified as the cause of long-standing digestive and fatigue symptoms, and high-carbohydrate diets worsened rather than improved symptoms
- What it means for you: If you’ve had unexplained digestive problems and fatigue for years without a clear diagnosis, genetic testing might reveal an underlying metabolic disorder. However, this is a rare condition, so most IBS cases have different causes. Talk to your doctor about whether genetic testing makes sense for your situation.
The Research Details
This research presents a detailed case report of one adult patient whose medical mystery was finally solved after 15 years. The doctors performed standard blood and urine tests that showed abnormally high levels of methylmalonic acid, a chemical that builds up when the body can’t process certain nutrients properly. They then used genetic testing to identify the specific mutation causing the problem. To understand how the mutation affected the patient’s cells, researchers grew cells from the patient’s skin and studied how they produced energy, finding that the mutation disrupted critical energy-making processes inside the cell’s mitochondria (the powerhouse of the cell).
The researchers also tested how different diets affected the patient. They tried a high-carbohydrate, low-protein diet, which is standard treatment for a similar but different condition, and found it made the patient’s digestive symptoms significantly worse. When the patient stopped following this diet, symptoms improved. This unexpected finding suggests that CMAMMA patients may need different dietary approaches than doctors currently recommend.
While this study involves only one patient, it provides important clues for doctors to recognize this rare condition in others who may have been misdiagnosed with common digestive disorders.
Case reports like this are crucial for rare diseases because they help doctors recognize conditions they might otherwise miss. When a patient has unexplained symptoms for many years, a detailed case report can serve as a diagnostic guide for other physicians. This study is particularly important because it shows that standard treatments for similar conditions might actually harm CMAMMA patients, suggesting that personalized treatment approaches are necessary.
This is a single case report, which means the findings apply to one person and cannot be generalized to all CMAMMA patients. However, the diagnosis was confirmed through multiple methods: genetic testing, biochemical markers, and cellular studies. The patient’s response to dietary changes provides real-world evidence about what works and what doesn’t. Readers should understand that while this case is well-documented, larger studies would be needed to confirm whether these findings apply to other CMAMMA patients.
What the Results Show
The patient presented with two main problems: chronic fatigue and irritable bowel syndrome symptoms that had persisted for 15 years without a clear diagnosis. Standard tests had not revealed the underlying cause. Blood and urine testing finally showed elevated levels of methylmalonic acid, a sign that the body’s energy-producing machinery wasn’t working properly.
Genetic testing identified a specific mutation in the ACSF3 gene (written as c.1672C>T), which the patient inherited from both parents. This gene normally helps the body make a molecule called malonyl-CoA, which is essential for energy production. When this gene is mutated, the body struggles to produce energy efficiently, particularly from carbohydrates.
Cellular studies confirmed the problem: cells from the patient showed abnormal patterns in how they marked proteins with a chemical tag called malonylation, and they had reduced ability to process pyruvate and α-ketoglutarate, two critical steps in energy production. This explains why the patient felt constantly exhausted.
Most surprisingly, when doctors prescribed a high-carbohydrate, low-protein diet (standard for a related condition), the patient’s digestive symptoms worsened dramatically. Once the patient stopped following this diet, symptoms improved significantly. This suggests that CMAMMA patients cannot efficiently process carbohydrates for energy, making high-carb diets counterproductive.
The case highlights that CMAMMA can present primarily with digestive and fatigue symptoms in adults, rather than the seizures and cognitive problems more commonly seen in children with this disorder. This variation in how the disease appears makes it easy to misdiagnose. The patient’s 15-year diagnostic journey also underscores how rare genetic disorders can be overlooked when they mimic more common conditions like IBS.
CMAMMA is an extremely rare condition, with only a handful of cases reported in medical literature. Most previously documented cases presented in childhood with neurological symptoms like seizures and developmental delays. This case is notable because it shows CMAMMA can remain undiagnosed into adulthood when it primarily causes digestive and fatigue symptoms. The finding that high-carbohydrate diets worsen symptoms contradicts standard dietary recommendations for related metabolic disorders, suggesting that CMAMMA requires a unique treatment approach.
This study describes only one patient, so the findings cannot be applied to all people with CMAMMA. Different patients may have different mutations in the ACSF3 gene and may respond differently to dietary changes. The patient’s response to diet is based on observation rather than a controlled experiment. Larger studies involving multiple CMAMMA patients would be needed to confirm whether high-carbohydrate diets consistently worsen symptoms and what the optimal diet should be. Additionally, this case report cannot determine how common CMAMMA is among people diagnosed with IBS, so doctors should not assume every IBS patient has this rare disorder.
The Bottom Line
If you have had unexplained digestive problems and fatigue for many years without a clear diagnosis, ask your doctor whether genetic testing for rare metabolic disorders might be appropriate (moderate confidence, applies to small subset of patients). If you are diagnosed with CMAMMA, work with a metabolic specialist rather than following standard IBS or similar-condition diets, as high-carbohydrate approaches may worsen symptoms (low confidence, based on one case, but important to consider). Do not self-diagnose or assume you have CMAMMA based on digestive symptoms alone; this is an extremely rare condition.
This research is most relevant to: (1) people with long-standing unexplained digestive and fatigue symptoms who haven’t received a diagnosis despite extensive testing; (2) doctors treating patients with suspected metabolic disorders; (3) genetic counselors and metabolic specialists; (4) people with known CMAMMA who need to understand their condition better. Most people with IBS or fatigue have other causes and should not assume they have CMAMMA.
In this case, dietary changes showed improvement within weeks of stopping the high-carbohydrate diet. However, this is a single patient, and recovery timelines may vary. Genetic testing results typically come back within 2-4 weeks. If CMAMMA is confirmed, working with a metabolic specialist to develop an appropriate diet plan would be the next step.
Frequently Asked Questions
Can irritable bowel syndrome actually be a rare genetic disorder?
Yes, in rare cases. A 2026 case report found one patient diagnosed with IBS for 15 years who actually had CMAMMA, a genetic mitochondrial disorder. While CMAMMA is extremely uncommon, it demonstrates that some unexplained digestive symptoms may have genetic causes. Most IBS cases have different origins, but genetic testing may be worth discussing with your doctor if symptoms persist despite standard treatments.
What is CMAMMA and how does it affect digestion?
CMAMMA is a rare genetic disorder where mutations in the ACSF3 gene impair the body’s ability to produce energy efficiently, particularly from carbohydrates. This energy deficit affects the digestive system, causing symptoms like those of IBS. The condition also disrupts how cells process pyruvate and α-ketoglutarate, critical molecules in energy production, leading to chronic fatigue alongside digestive problems.
Should people with IBS try low-carb diets based on this case?
Not necessarily. This case involved one patient with a rare genetic disorder, not typical IBS. High-carbohydrate diets help most IBS patients, but worsened symptoms in this CMAMMA patient. Dietary approaches should be personalized based on your specific condition. Consult your doctor before making major dietary changes, especially if you have unexplained symptoms lasting years.
How is CMAMMA diagnosed and what tests are needed?
CMAMMA diagnosis involves blood and urine tests showing elevated methylmalonic acid levels, followed by genetic testing to identify ACSF3 mutations. Cellular studies can confirm impaired energy metabolism. If you have unexplained fatigue and digestive symptoms for years, ask your doctor whether metabolic screening and genetic testing are appropriate for your situation.
How common is CMAMMA and should I worry I have it?
CMAMMA is extremely rare, with only a handful of cases reported in medical literature. You should not assume you have it based on digestive symptoms alone. However, if you’ve had unexplained fatigue and digestive problems for many years without diagnosis despite standard testing, mention CMAMMA to your doctor as a possibility worth investigating through appropriate genetic testing.
Want to Apply This Research?
- If you have CMAMMA or suspect you might, track daily energy levels (1-10 scale), digestive symptoms (frequency and severity of bloating, pain, or other issues), and what you ate. Record this daily to identify which foods improve or worsen your symptoms. Share this data with your doctor to refine your personalized diet plan.
- Work with your healthcare provider to experiment with lower-carbohydrate approaches if you have CMAMMA, rather than following standard high-carb recommendations for IBS. Use the app to log your symptoms before and after dietary changes to see what works for your body. This personalized approach may be more effective than generic dietary advice.
- Establish a baseline of your current symptoms and energy levels, then track changes weekly as you adjust your diet. Monitor for patterns: Do certain foods consistently make symptoms worse? Do you feel more energetic on lower-carb days? Use this long-term data to identify your personal optimal diet and share trends with your healthcare team during regular check-ins.
This article describes a single case report of a rare genetic disorder and should not be used for self-diagnosis. CMAMMA is extremely uncommon, and most people with digestive symptoms or IBS have other causes. If you have persistent unexplained fatigue and digestive problems, consult with a qualified healthcare provider or gastroenterologist before pursuing genetic testing. Do not modify your diet based on this case report without medical guidance. This information is educational and does not replace professional medical advice, diagnosis, or treatment. Always work with your healthcare team to develop an appropriate diagnostic and treatment plan for your individual situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
